Reports

As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Asia Pacific Drug Development Market: By Mode: In House, Outsourced; By Process Step: Process Research Development, Formulation, Analytical & Stability Studies, Others; By Therapeutic Area; Regional Analysis; Historical Market and Forecast (2016-2026); Market Dynamics; Competitive Landscape; Industry Events and Developments

Asia Pacific Drug Development Market Outlook

The Asia Pacific drug development market reached USD 38.23 billion in 2020 and is projected to grow at a CAGR of 7.1% over the 2021-2026 forecast period.

 

Asia Pacific Drug Development Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The changing market dynamics, such as the constant growth of the pharmerging market, coupled with the saturated growth rates in established markets, are driving the growth of the drug development market in the Asia Pacific. Also, capital inflows from the western region in the Asian pharmaceutical industry offer substantial opportunities for business expansion to new entrants.

 

Properties and Applications

Drug development is the method of developing a new drug once a lead compound has been discovered through the drug discovery method. The Asia Pacific drug development industry can be divided on the basis of segments like mode, process step, and therapeutic area.

 

Asia Pacific Drug Development Market By Mode

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The industry can be broadly categorised based on mode into:

  • In House
  • Outsourced

The industry can be divided on the basis of process step as:

  • Process Research Development
  • Formulation
  • Analytical and Stability Studies
  • Drug Metabolism and Pharmacokinetics (DMPK)
  • Safety Assessment (Toxicology)
  • Regulatory Compliance
  • Packaging

The industry can be divided based on the therapeutic area:

  • Oncology
  • Inflammation and Immunology
  • Cardiology            
  • Neuroscience
  • Others

The EMR report looks into the Asia Pacific drug development markets like India, Japan, and China.

 

Asia Pacific Drug Development Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Analysis

Regulatory authorities such as the China Food and Drug Administration have made significant improvements in addressing critical system gaps. These are working to provide the basis for enhancing the registration process and driving developments in the drug development market in the Asia Pacific in order to stimulate growth. In the clinical trials, companies have efficiently shifted from giving a value proposition based on "speed and cost" to value-added proposals. It involves the transition from early-stage licensing to later stage licensing for growth. However, the trend for business model charges, as well as risk-sharing and collaborations, are being adopted. The rise in new product launches depicts the remarkable growth within the Asia Pacific drug development industry. The cost-saving advantages of the Asian market have prompted global companies to integrate Asia into its global framework for drug development. However, to some degree, the existence of some constraints in the area is anticipated to hinder growth. One of these problems is that the study promoters have to pay the cost of studies and research in Asia, whereas insurance providers and government payers in the western countries make payments throughout the trial for the general healthcare costs of enrolled patients. Nevertheless, the average cost of running studies in the Asia Pacific is significantly lower than in the West, thus, reducing the impact of this constraint.

 

Competitive Landscape

The report presents a detailed analysis of the following key players in the Asia Pacific drug development market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Samsung Biologics
  • WuXi Biologics
  • Celltrion Inc.
  • PT Kalbe Farma Tbk.
  • Eurofins Advinus
  • Others

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter's Five Forces model.

 

REPORT FEATURES DETAILS
Base Year 2020
Historical Period 2016-2020
Forecast Period 2021-2026
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Mode, Process Step, Therapeutic Area, Region
Breakup by Mode In House, Outsourced
Breakup by Process Step Process Research Development, Formulation, Analytical and Stability Studies, Drug Metabolism and Pharmacokinetics (DMPK), Safety Assessment (Toxicology), Regulatory Compliance, Packaging
Breakup by Therapeutic Area Oncology, Inflammation and Immunology, Cardiology, Neuroscience, Others
Breakup by Region China, Japan, India
Market Dynamics SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered Samsung Biologics, WuXi Biologics, Celltrion Inc., PT Kalbe Farma Tbk., Eurofins Advinus, Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Asia Pacific
7    Industry Opportunities and Challenges
8    Asia Pacific Drug Development Market Analysis

    8.1    Key Industry Highlights
    8.2    Asia Pacific Drug Development Historical Market (2016-2020) 
    8.3    Asia Pacific Drug Development Market Forecast (2021-2026)
    8.4    Asia Pacific Drug Development Market by Mode
        8.4.1    In House
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2016-2020)
            8.4.1.3    Forecast Trend (2021-2026)
        8.4.2    Outsourced
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2016-2020)
            8.4.2.3    Forecast Trend (2021-2026)
    8.5    Asia Pacific Drug Development Market by Process Step
        8.5.1    Process Research Development
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2016-2020)
            8.5.1.3    Forecast Trend (2021-2026)
        8.5.2    Formulation
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2016-2020)
            8.5.2.3    Forecast Trend (2021-2026)
        8.5.3    Analytical and Stability Studies
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2016-2020)
            8.5.3.3    Forecast Trend (2021-2026)
        8.5.4    Drug Metabolism and Pharmacokinetics (DMPK)
            8.5.4.1    Market Share
            8.5.4.2    Historical Trend (2016-2020)
            8.5.4.3    Forecast Trend (2021-2026)
        8.5.5    Safety Assessment (Toxicology)
            8.5.5.1    Market Share
            8.5.5.2    Historical Trend (2016-2020)
            8.5.5.3    Forecast Trend (2021-2026)
        8.5.6    Regulatory Compliance
            8.5.6.1    Market Share
            8.5.6.2    Historical Trend (2016-2020)
            8.5.6.3    Forecast Trend (2021-2026)
        8.5.7    Packaging
            8.5.7.1    Market Share
            8.5.7.2    Historical Trend (2016-2020)
            8.5.7.3    Forecast Trend (2021-2026)
    8.6    Asia Pacific Drug Development Market by Therapeutic Area
        8.6.1    Oncology
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2016-2020)
            8.6.1.3    Forecast Trend (2021-2026)
        8.6.2    Inflammation and Immunology
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2016-2020)
            8.6.2.3    Forecast Trend (2021-2026)
        8.6.3    Cardiology
            8.6.3.1    Market Share
            8.6.3.2    Historical Trend (2016-2020)
            8.6.3.3    Forecast Trend (2021-2026)
        8.6.4    Neuroscience
            8.6.4.1    Market Share
            8.6.4.2    Historical Trend (2016-2020)
            8.6.4.3    Forecast Trend (2021-2026)
        8.6.5    Others
    8.7    Asia Pacific Drug Development Market by Region
        8.7.1    Market Share
            8.7.1.1    China
            8.7.1.2    Japan
            8.7.1.3    India
9    Regional Analysis
    9.1    China
        9.1.1    Historical Trend (2016-2020)
        9.1.2    Forecast Trend (2021-2026)
    9.2    Japan
        9.2.1    Historical Trend (2016-2020)
        9.2.2    Forecast Trend (2021-2026)
    9.3    India
        9.3.1    Historical Trend (2016-2020)
        9.3.2    Forecast Trend (2021-2026)
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    EMR’s Key Indicators for Demand
    10.4    EMR’s Key Indicators for Price
11    Value Chain Analysis
12    Competitive Landscape

    12.1    Market Structure
    12.2    Company Profiles
        12.2.1    Samsung Biologics
            12.2.1.1    Company Overview
            12.2.1.2    Product Portfolio
            12.2.1.3    Demographic Reach and Achievements
            12.2.1.4    Certifications
        12.2.2    WuXi Biologics
            12.2.2.1    Company Overview
            12.2.2.2    Product Portfolio
            12.2.2.3    Demographic Reach and Achievements
            12.2.2.4    Certifications
        12.2.3    Celltrion Inc.
            12.2.3.1    Company Overview
            12.2.3.2    Product Portfolio
            12.2.3.3    Demographic Reach and Achievements
            12.2.3.4    Certifications
        12.2.4    PT Kalbe Farma Tbk.
            12.2.4.1    Company Overview
            12.2.4.2    Product Portfolio
            12.2.4.3    Demographic Reach and Achievements
            12.2.4.4    Certifications
        12.2.5    Eurofins Advinus
            12.2.5.1    Company Overview
            12.2.5.2    Product Portfolio
            12.2.5.3    Demographic Reach and Achievements
            12.2.5.4    Certifications
        12.2.6    Others
13    Industry Events and Developments


List of Figures and Tables

1.    Asia Pacific Drug Development Market: Key Industry Highlights, 2016 and 2026
2.    Asia Pacific Drug Development Historical Market: Breakup by Mode (USD Billion), 2016-2020
3.    Asia Pacific Drug Development Market Forecast: Breakup by Mode (USD Billion), 2021-2026
4.    Asia Pacific Drug Development Historical Market: Breakup by Process Step (USD Billion), 2016-2020
5.    Asia Pacific Drug Development Market Forecast: Breakup by Process Step (USD Billion), 2021-2026
6.    Asia Pacific Drug Development Historical Market: Breakup by Therapeutic Area (USD Billion), 2016-2020
7.    Asia Pacific Drug Development Market Forecast: Breakup by Therapeutic Area (USD Billion), 2021-2026
8.    Asia Pacific Drug Development Historical Market: Breakup by Region (USD Billion), 2016-2020
9.    Asia Pacific Drug Development Market Forecast: Breakup by Region (USD Billion), 2021-2026
10.    Asia Pacific Drug Development Market Structure

Key Questions Answered in the Report

In 2020, the Asia Pacific drug development market attained a value of nearly USD 38.23 billion.

The market is projected to grow at a CAGR of 7.1% between 2021 and 2026.

The major drivers of the industry include rising population, substantial opportunities for business expansion, lower costs in Asia and improving registration processes.

The constant growth of the pharmaceutical market, coupled with the saturated growth rates in established markets, is expected to be a key trend guiding the growth of the industry.

The types of drug development available are in house and outsourced.

Drug development can have different process steps like process research development, formulation, analytical and stability studies, drug metabolism and pharmacokinetics (DMPK), safety assessment (toxicology), regulatory compliance and packaging.

Oncology, inflammation and immunology, cardiology, and neuroscience, amongst others are some therapeutic areas for the drug development market.

The leading players in this market are Samsung BioLogics, WuXi Biologics, Celltrion Inc., PT Kalbe Farma Tbk, Eurofins Advinus, Covance Inc., Celerion Inc., and Parexel International Corporation, amongst others.

Analyst Review

The Asia Pacific drug development market attained a value of USD 38.23 billion in 2020, driven by the substantial opportunities for business expansion and the lower costs in Asia and improving registration processes. The market is expected to witness a further growth in the forecast period of 2021-2026, growing at a CAGR of 7.1%.

EMR’s meticulous research methodology delves deep into the industry, covering the macro and micro aspects of the industry. Based on the mode of deployment, the drug development market can be segmented into in house and outsourced. By process step, the industry can be divided into process research development, formulation, analytical and stability studies, drug metabolism and pharmacokinetics (DMPK), safety assessment (Toxicology), regulatory compliance and packaging. Oncology, inflammation and immunology, cardiology, and neuroscience, amongst others are some therapeutic areas for the drug development market. The key players in the above industry include Samsung BioLogics, WuXi Biologics, Celltrion Inc., PT Kalbe Farma Tbk, Eurofins Advinus, Covance Inc., Celerion Inc., and Parexel International Corporation, amongst others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER